Sickle Cell Scholar

镰状细胞学者的行政结构是专门设计的，以便希勒里博士和 博士德邦可以共同确定学员和促进他们的职业成长和发展的镰刀 细胞疾病相关的转化研究。该学者的招聘将针对年轻的调查人员 目前参与镰状细胞病或儿科哮喘研究，包括博士后研究员和 初级学院。学者可以在威斯康星州或华盛顿医学院工作 大学医学院。被选中的候选人将参加拟议的翻译 项目，这是基于这两个网站，以确保他或她的学术和实践经验， 充分涵盖基础科学或临床研究的培训。预计学者将 开发翻译项目5中开发的主题的新颖方面，以完成值得注意的 这项研究大大增强了我们对炎症通路相互作用的理解， 肺部疾病合并镰状细胞病镰状细胞学者预计将花费至少75 他/她对这个项目的努力，包括职业发展活动的百分之。此外该 镰状细胞学者将被鼓励和指导申请资金，以支持新的利益， 这是他们参与项目5的结果。一个学者咨询委员会，将包括两个医疗 威斯康星州学院和华盛顿大学医学院的基础教师，和外部成员 根据需要，将为学者提供关于其研究计划的持续建议。作为大学校长 希勒里博士和德邦博士将投入至少5%的共同努力，这将是 在整个项目5的努力。Cheryl Hillery和Michael DeBaun，共同导师，将 负责镰状细胞学者的跟踪和评估。镰状细胞学者 该计划旨在增加合格的调查人员谁拥有专业知识和职业生涯的临界质量 进行镰状细胞病研究的动机。

The administrative structure of the Sickle Cell Scholar is specifically designed so that Dr. Hillery and Dr. DeBaun can work together to identify trainees and foster their career growth and development of sickle cell disease-related translational research. Recruitment for the scholar will target young investigators currently involved in sickle cell disease or pediatric asthma research, including Postdoctoral Fellows and Junior Faculty. The Scholar can be based at either the Medical College of Wisconsin or Washington University School of Medicine. The selected candidate will participate in the proposed Translational Projects, which is based at both sites, to ensure his or her scholarly and practical exposures will sufficiently encompass training in either basic science or clinical research. The Scholar will be expected to develop a novel aspect of the theme developed in Translational Project 5 so as to complete noteworthy research that significantly augments our understanding of the interaction of the inflammatory pathways and pulmonary disease with sickle cell disease. The Sickle Cell Scholar will be expected to spend at least 75 percent of his/her effort towards this project, including career development activities. In addition, the Sickle Cell Scholar will be encouraged and mentored to apply for funding to support new interests that may result from their participation in Project 5. A Scholar Advisory Committee that will include both Medical College of Wisconsin and Washington University School of Medicine-based faculty, and external members as needed, will function to provide the Scholar with continuing advice on his/her research program. As coleaders of Project 5, Drs. Hillery and DeBaun will devote a minimum of 5% joint effort, which will be included within the overall Project 5 effort. Cheryl Hillery and Michael DeBaun, Co-Mentors, will be responsible for tracking and evaluation of the Sickle Cell Scholar. The proposed Sickle Cell Scholar program aims to increase the critical mass of qualified investigators who possess the expertise and career motivation to conduct research in Sickle Cell Disease.